Science Explorer Back to mapMap
Discussion
Nonprofit · San Carlos · United States

Go2 for Lung Cancer

go2.orgROR OpenAlex
Research works
72
▲ 68% vs 2018-21
Citations
161
2.3 per fractional work
Top-10% rate
2.7%
all institutions 10.0%
Open access
57%
world 40%
International
16%
world 18%
Go2 for Lung Cancer

Not ranked overall: Go2 for Lung Cancer is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Go2 for Lung Cancer work in?

In 2022-now, 80% of research at Go2 for Lung Cancer is in Health Sciences, 16% in Social Sciences. Its largest fields are Medicine (74%), Economics, Econometrics and Finance (12%), Health Professions (5%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 31 fractional works · 80.2% of its workMedicine: 29 fractional works · 74.0% of its workOncology: 10 fractional works · 26.0% of its workPulmonary and Respiratory Medicine: 8 fractional works · 20.4% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 9.9% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 7.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.4% of its workHealth Informatics: 0 fractional works · 1.3% of its workEpidemiology: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 5.4% of its workGeneral Health Professions: 2 fractional works · 5.1% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.9% of its workIssues, ethics and legal aspects: 0 fractional works · 0.9% of its workSocial Sciences: 6 fractional works · 16.1% of its workEconomics, Econometrics and Finance: 5 fractional works · 11.7% of its workEconomics and Econometrics: 5 fractional works · 11.7% of its workSocial Sciences: 2 fractional works · 4.4% of its workSociology and Political Science: 1 fractional works · 2.6% of its workHealth: 1 fractional works · 1.5% of its workCommunication: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workLife Sciences: 1 fractional works · 2.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 2.0% of its workGenetics: 0 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.6% of its workMolecular Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.0% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workEngineering: 0 fractional works · 0.2% of its workALL ITS WORKGo2 for LungCancer39fractional works, 2022-now
Life Sciences2%Physical Sciences2%Health Sciences80%Social Sciences16%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine2974.0%
    2. Health Professions25.4%
    3. Nursing00.9%
    1. Economics, Econometrics and Finance511.7%
    2. Social Sciences24.4%
    1. Biochemistry, Genetics and Molecular Biology12.0%
    2. Immunology and Microbiology00.1%
    1. Environmental Science01.0%
    2. Mathematics00.4%
    3. Engineering00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Go2 for Lung Cancer specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.9× the share of its output that it takes of world research.

  1. MedicineField · 28.7 works3.9×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.37× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.12× its world share, 0 worksImmunology and Micro…Engineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMathematics: 0.37× its world share, 0 worksMathematicsHealth Professions: 2.06× its world share, 2 worksHealth ProfessionsMedicine: 3.85× its world share, 29 worksMedicineNursing: 1.76× its world share, 0 worksNursingEconomics, Econometrics and Finance: 5.47× its world share, 4 worksEconomics, Econometr…Social Sciences: 0.34× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.5×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Economics, Econometrics and Finance5.47×4 works
  2. Medicine3.85×29 works
  3. Health Professions2.06×2 works
  4. Nursing1.76×0 works
  5. Biochemistry, Genetics and Molecular Biology0.37×1 works
  6. Mathematics0.37×0 works
  7. Social Sciences0.34×2 works
  8. Environmental Science0.20×0 works
  9. Immunology and Microbiology0.12×0 works
  10. Engineering0.01×0 works

Who are the top researchers at Go2 for Lung Cancer?

Ranked on the quality score, Jacinta Wiens, Jennifer C. King and Courtney A. Granville lead among researchers whose main affiliation is Go2 for Lung Cancer.

  1. 1 Jacinta Wiens United States · #751,767 worldwide 1.3k citations · 18 works
  2. 2 Jennifer C. King United States · #942,730 worldwide 2.2k citations · 116 works
  3. 3 Courtney A. Granville United States · #1,058,549 worldwide 1.7k citations · 39 works
  4. 4 Joelle Thirsk Fathi United States · #1,804,593 worldwide 933 citations · 48 works
  5. 5 Bonnie J. Addario United States · #2,780,683 worldwide 237 citations · 32 works
  6. 6 Shanada Monestime United States · #3,025,501 worldwide 178 citations · 35 works
  7. 7 David Leduc United States · #3,694,847 worldwide 25 citations · 17 works
  8. 8 Andrew Ciupek United States · #3,883,055 worldwide 223 citations · 49 works
  9. 9 Sandra S. Shaw United States · #4,513,258 worldwide 121 citations · 21 works
All ranked researchers at Go2 for Lung Cancer

What are the most cited papers from Go2 for Lung Cancer?

The most cited paper from Go2 for Lung Cancer is "Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation" (Christian Rolfo, Noy Meshulami, Alessandro Russo et al., 2021), with 54 citations. Next come "Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials" (54) and "Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma" (52).

Most cited papers
#PaperReleasedCitations
1 Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation Christian Rolfo, Noy Meshulami, Alessandro Russo et al. · Journal of Thoracic Oncology Open access 10 Nov 2021 54
2 Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials Bonnie J. Addario, Jan Geißler, Marcia K. Horn et al. · Health Expectations Open access 13 Nov 2019 54
3 Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma Smita C. Banerjee, Noshin Haque, Elizabeth Schofield et al. · CHEST Journal Open access 16 Dec 2020 52
4 Responding empathically to patients: a communication skills training module to reduce lung cancer stigma Smita C. Banerjee, Noshin Haque, Carma L. Bylund et al. · Translational Behavioral Medicine Open access 21 Feb 2020 47
5 Patient value: Perspectives from the advocacy community Bonnie J. Addario, Ana Fadich, Jesme Fox et al. · Health Expectations Open access 20 Sep 2017 36
All 79 most cited papers, with filters and sorting

Which keywords describe research at Go2 for Lung Cancer?

By fractional works in 2022-now, weighted toward what it does more of than the world: Clinical Trials, Chemotherapy, Targeted Therapy, Risk Factors, Cancer Incidence, Radiotherapy, Population-Based Study and Preventive Services.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials8▲ 32×6 topics
  2. Chemotherapy7▲ 25×8 topics
  3. Targeted Therapy6▲ 75×3 topics
  4. Risk Factors5▲ 12×3 topics
  5. Cancer Incidence4▲ 82×3 topics
  6. Radiotherapy4▲ 28×3 topics
  7. Population-Based Study4▲ 165×2 topics
  8. Preventive Services4▲ 179×2 topics
  9. Global Surveillance4▲ 225×1 topic
  10. Mortality Rates4▲ 109×1 topic
  11. ALK Inhibitors4▲ 155×1 topic
  12. Adjuvant Therapy4▲ 77×2 topics
  13. CT Screening4▲ 139×1 topic
  14. EGFR Mutations4▲ 155×1 topic
  15. Lung Cancer4▲ 56×1 topic
  16. Cost of Care4▲ 301×1 topic
  17. Financial Toxicity4▲ 301×1 topic
  18. Precision Medicine3▲ 17×5 topics
  19. Biomarkers3▲ 11×4 topics
  20. Quality of Life3▲ 5.1×3 topics
  21. Ethical Considerations3▲ 20×2 topics
  22. Health-related Quality of Life3▲ 28×2 topics
  23. Immunotherapy3▲ 9.3×2 topics
  24. Machine Learning3▲ 2.0×2 topics
  25. Medical Imaging3▲ 13×2 topics
  26. Prognostic Factors3▲ 16×3 topics
  27. Genomic Profiles2▲ 146×1 topic
  28. Small-Cell Lung Cancer2▲ 146×1 topic
  29. Cancer Survivorship2▲ 80×2 topics
  30. Depression2▲ 6.4×2 topics
  31. Health Care Costs2▲ 71×2 topics
  32. Anxiety2▲ 12×1 topic
  33. End-of-Life2▲ 62×1 topic
  34. Palliative Care2▲ 36×1 topic
  35. Patient-Reported Outcomes2▲ 99×1 topic
  36. Quantitative Analysis2▲ 26×1 topic
  37. Radiomics2▲ 48×1 topic
  38. Community Engagement1▲ 10×2 topics
  39. Informed Consent1▲ 42×1 topic
  40. Research Participation1▲ 120×1 topic

Which research topics does Go2 for Lung Cancer publish most on?

By volume in 2022-now: Global Cancer Incidence and Screening, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Economic and Financial Impacts of Cancer.

Global Cancer Incidence …4Global Cancer Incidence and Screening: 4 fractional worksLung Cancer Treatments a…4Lung Cancer Treatments and Mutations: 4 fractional worksLung Cancer Diagnosis an…4Lung Cancer Diagnosis and Treatment: 4 fractional worksEconomic and Financial I…4Economic and Financial Impacts of Cancer: 4 fractional worksLung Cancer Research Studies: 2 fractional worksPalliative Care and End-of-Life Issues: 2 fractional worksRadiomics and Machine Le…2Radiomics and Machine Learning in Medical Imaging: 2 fractional worksCancer survivorship and care: 2 fractional worksEthics in Clinical Research: 1 fractional worksCardiovascular Health and Risk Factors: 1 fractional works
OncologyPulmonary and Respiratory MedicineEconomics and EconometricsPublic Health, Environmental and Occupational Health2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 4 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  3. 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 4 works
  5. 5 Lung Cancer Research Studies Oncology 2 works
  6. 6 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 2 works
  7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
  8. 8 Cancer survivorship and care Oncology 2 works
  9. 9 Ethics in Clinical Research Public Health, Environmental and Occupational Health 1 works
  10. 10 Cardiovascular Health and Risk Factors Cardiology and Cardiovascular Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.1%not open42.9%

World: 40% of research is openly available.

with international co-authors15.5%domestic only84.5%

World: 18% is written across borders.

How has Go2 for Lung Cancer's research output changed?

Output in 2022-2025 was 68% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Go2 for Lung Cancer as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00020%0.00040%Go2 for Lung Cancer0.00027% in 202519801990200020102020

Fractional works of Go2 for Lung Cancer over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Carlos

All research institutions in San Carlos

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Go2 for Lung Cancer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.